135 related articles for article (PubMed ID: 18236715)
1. Clinical application of EGFR inhibitors in head and neck squamous cell cancer.
Astsaturov I; Cohen RB; Harari PM
Cancer Treat Res; 2008; 139():135-52. PubMed ID: 18236715
[No Abstract] [Full Text] [Related]
2. Epidermal growth factor receptor biology in head and neck cancer.
Kalyankrishna S; Grandis JR
J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281
[TBL] [Abstract][Full Text] [Related]
3. Integrating novel agents into the curative treatment of head and neck cancer.
Haddad R; Allen A; Wirth L; Tishler R; Posner M
Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367
[No Abstract] [Full Text] [Related]
4. Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer.
Astsaturov I; Cohen RB; Harari P
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1179-93. PubMed ID: 17020453
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for head and neck cancer: latest developments and future perspectives.
Bernier J; Bentzen SM
Curr Opin Oncol; 2006 May; 18(3):240-6. PubMed ID: 16552235
[TBL] [Abstract][Full Text] [Related]
6. Emerging molecular targeted therapies in squamous cell carcinoma of the head and neck.
Gilbert J; Argiris A
Clin Adv Hematol Oncol; 2006 Aug; 4(8):611-9. PubMed ID: 17099619
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of molecularly targeted agents in the primary treatment of squamous cell carcinomas of the head and neck.
Bernier J
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1193-208, ix. PubMed ID: 19010268
[TBL] [Abstract][Full Text] [Related]
8. Targeted radionuclide therapy in head and neck cancer.
Nestor MV
Head Neck; 2010 May; 32(5):666-78. PubMed ID: 19827126
[TBL] [Abstract][Full Text] [Related]
9. Second-line chemotherapy in head and neck cancer: what should we expect?
Büntzel J; Micke O
Expert Rev Anticancer Ther; 2009 Mar; 9(3):269-73. PubMed ID: 19275504
[No Abstract] [Full Text] [Related]
10. Increasing toxicity in nonoperative head and neck cancer treatment: investigations and interventions.
Bentzen SM; Rosenthal DI; Weymuller EA; Trotti A
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S79-82. PubMed ID: 17848301
[No Abstract] [Full Text] [Related]
11. Epidermal growth factor receptor-targeted therapy.
West CM; Joseph L; Bhana S
Br J Radiol; 2008 Oct; 81 Spec No 1():S36-44. PubMed ID: 18819997
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemotherapy and radiotherapy for head and neck cancer.
Burri RJ; Lee NY
Expert Rev Anticancer Ther; 2009 Mar; 9(3):293-302. PubMed ID: 19275508
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations.
Harari PM; Ritter MA; Petereit DG; Mehta MP
Curr Probl Cancer; 2004; 28(1):7-40. PubMed ID: 14688789
[No Abstract] [Full Text] [Related]
14. Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization.
Gee JM; Nicholson RI
Breast Cancer Res; 2003; 5(3):126-9. PubMed ID: 12793892
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of low-dose cisplatin-based chemo-irradiation in assessing hearing loss for locally advanced head and neck cancer.
Liao XB; Yan SX
Radiother Oncol; 2009 Feb; 90(2):282, author reply 282-3. PubMed ID: 19042049
[No Abstract] [Full Text] [Related]
16. Head and neck cancer carcinoma: new directions for treatment.
Posner MR
MedGenMed; 2002 Jun; 4(3):15. PubMed ID: 12466758
[No Abstract] [Full Text] [Related]
17. Induction chemotherapy: to use or not to use? That is the question.
Brizel DM; Vokes EE
Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
[TBL] [Abstract][Full Text] [Related]
18. Preradiation peplomycin for advanced squamous cell carcinomas.
Azhar T; Singh P
Med J Malaysia; 1988 Mar; 43(1):40-3. PubMed ID: 2468988
[No Abstract] [Full Text] [Related]
19. Targeting important pathways in head and neck cancer: from the bench to the clinic.
Santos ES; Perez C; Donald CE; Raez LE
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1819-35. PubMed ID: 18983242
[TBL] [Abstract][Full Text] [Related]
20. Benefits of chemotherapy in head and neck cancer.
Brockstein B
Lancet; 2000 Aug; 356(9231):767-8. PubMed ID: 11085713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
